Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 9Thoracic 3Head & Neck 2Breast 2Genitourinary 1

Conditions

Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 3Breast Neoplasms 2Urinary Bladder Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 61Carboplatin 44Pemetrexed 31Paclitaxel 31Docetaxel 31Cisplatin 27Gemcitabine 24Nivolumab 23Erlotinib Hydrochloride 21Bevacizumab 18Ipilimumab 11osimertinib 10Drug Therapy 10atezolizumab 9Radiosurgery 9Cyclophosphamide 9Cetuximab 9Blood Specimen Collection 9durvalumab 8cemiplimab 8Radiotherapy 8budigalimab 7Fluorouracil 7Dexamethasone 7trametinib 6fludarabine 6dostarlimab 6avelumab 6Taxes 6130-nm albumin-bound paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Positron Emission Tomography Computed Tomography × Thoracic × Clear all
NCT07487883 2026-04-02

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Peking University People's Hospital

Recruiting
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Pulmonary Nodules

NCT05835570 2025-04-30

Integrin αvβ6-targeted PET in Malignant Tumors

Zhongnan Hospital

Recruiting
200 enrolled
BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT01479348 2020-06-02

Imaging Study for FdCyd and THU Cancer Treatment

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
5 enrolled 12 charts
BreastGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡